NEU 6.41% $15.27 neuren pharmaceuticals limited

evidence, page-5

  1. 506 Posts.
    lightbulb Created with Sketch. 73
    if there was any doubt about efficacy this would not be proceeding to phase III.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.